U.S. market Closed. Opens in 20 hours 55 minutes

ADILW | Adial Pharmaceuticals, Inc. WT EXP 073123 Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
RevenueN/AN/AN/AN/AN/A
Cost of Revenue564.0060.50K55.11K564.00565.00
Gross Profit-564.00-60.50K-55.11K-564.00-565.00
Operating Expenses6.89M13.32M17.74M10.93M8.24M
Selling, General & Admin5.62M9.14M9.34M5.07M4.28M
Research & Development1.27M4.18M8.40M5.85M3.97M
Other Operating ExpensesN/AN/A46.49K2.50KN/A
Operating Income-6.89M-13.32M-19.29M-10.93M-8.24M
Other Expenses / Income-113.94K585.21K-1.82M34.99K-346.53K
Before Tax Income-7.00M-12.73M-19.52M-10.89M-8.59M
Income Tax ExpensesN/A-502.00-94.08K-32.49K-76.06K
Net Income-7.00M-12.73M-19.42M-10.86M-8.59M
Interest ExpensesN/AN/AN/AN/AN/A
Basic Shares Outstanding1.42M1.06M743.55K498.52K394.10K
Diluted Shares Outstanding1.42M1.06M743.55K498.52K394.10K
EBITDA-7.00M-13.32M-19.46M-10.93M-8.15M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%
EBIT-7.00M-12.73M-19.52M-10.89M-8.67M
EBIT Margin0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙